Tag - diagnosis

Abbott to acquire Exact Sciences

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity

Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

Genoox and Aspira Women’s Health Inc. Partner to Develop and Deliver Data-Driven Insights to Advance Women’s Health

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics

ClinSpec Dx receive £2.4m funding boost

Life of a Clinical Geneticist: Dealing Often With Heartless Bureaucracy

Copyright © 2026. enlighenbio LLC. All rights reserved.